Literature DB >> 12023155

The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment.

Joost J Nuyttens1, John M Robertson, Di Yan, Alvaro Martinez.   

Abstract

PURPOSE: This study defined the clinical target volume (CTV) for the adjuvant treatment of rectal cancer and applied this definition to multiple CT scans obtained during the typical 5-week course of treatment to measure the modification to the CTV due to internal organ motion that would be needed to define the planning target volume (PTV). METHODS AND MATERIALS: Ten patients with rectal cancer had weekly treatment planning CT scans during adjuvant radiation therapy. All patients were given oral contrast, placed prone on a rigid foam cradle with a depressed area for small bowel exclusion, and instructed to have a full bladder. The CT scans were registered according to the bones of the pelvis, and the CTV was outlined on each CT slice. Movement of the CTV in all dimensions was measured. The CT scan with the lowest and highest bladder volume for each patient was used to calculate the CTV movement due to bladder filling.
RESULTS: The largest difference in the CTV occurred 10 cm caudal to the anus, with a standard deviation of 1 cm. Bladder filling displaced the anterior border of the CTV an average of 7 mm over a cranial to caudal length of 2.5 cm. Other borders of the CTV were based on muscle, bone, or major blood vessels and were stable.
CONCLUSION: Modification of the CTV to design a PTV can be unequal, with the largest change at the anterior border of the inferior pelvis.

Entities:  

Mesh:

Year:  2002        PMID: 12023155     DOI: 10.1016/s0360-3016(02)02753-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Cone-beam computed tomography for organ motion evaluation in locally advanced rectal cancer patients.

Authors:  Consuelo Rosa; Luciana Caravatta; Monica Di Tommaso; David Fasciolo; Lucrezia Gasparini; Fiorella Cristina Di Guglielmo; Antonietta Augurio; Annamaria Vinciguerra; Claudio Vecchi; Domenico Genovesi
Journal:  Radiol Med       Date:  2020-04-15       Impact factor: 3.469

2.  Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications.

Authors:  Leire Arbea; Luis Isaac Ramos; Rafael Martínez-Monge; Marta Moreno; Javier Aristu
Journal:  Radiat Oncol       Date:  2010-02-26       Impact factor: 3.481

3.  Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.

Authors:  Robert J Myerson; Michael C Garofalo; Issam El Naqa; Ross A Abrams; Aditya Apte; Walter R Bosch; Prajnan Das; Leonard L Gunderson; Theodore S Hong; J J John Kim; Christopher G Willett; Lisa A Kachnic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-29       Impact factor: 7.038

4.  Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer.

Authors:  Hilke Vorwerk; Thorsten Liersch; Hilka Rothe; Michael Ghadimi; Hans Christiansen; Clemens Friedrich Hess; Robert Michael Hermann
Journal:  Strahlenther Onkol       Date:  2009-02-25       Impact factor: 3.621

5.  Neoadjuvant PET and MRI-based intensity modulated radiotherapy leads to less toxicity and improved pathologic response rates in locally advanced rectal cancer.

Authors:  John M David; Gillian Gresham; Salma K Jabbour; Matthew Deek; Shant Thomassian; John M Robertson; Neil B Newman; Joseph M Herman; Arsen Osipov; Peyman Kabolizadeh; Richard Tuli
Journal:  J Gastrointest Oncol       Date:  2018-08

6.  Analysis of motion of the rectum during preoperative intensity modulated radiation therapy for rectal cancer using cone-beam computed tomography.

Authors:  Hideomi Yamashita; Ryousuke Takenaka; Akira Sakumi; Akihiro Haga; Kuni Otomo; Keiichi Nakagawa
Journal:  Radiat Oncol       Date:  2015-01-08       Impact factor: 3.481

7.  Online adaptive radiotherapy compared to plan selection for rectal cancer: quantifying the benefit.

Authors:  R de Jong; K F Crama; J Visser; N van Wieringen; J Wiersma; E D Geijsen; A Bel
Journal:  Radiat Oncol       Date:  2020-07-08       Impact factor: 3.481

Review 8.  Realizing the potential of magnetic resonance image guided radiotherapy in gynaecological and rectal cancer.

Authors:  Ingrid M White; Erica Scurr; Andreas Wetscherek; Gina Brown; Aslam Sohaib; Simeon Nill; Uwe Oelfke; David Dearnaley; Susan Lalondrelle; Shreerang Bhide
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

9.  A comparison of dosimetric parameters between tomotherapy and three-dimensional conformal radiotherapy in rectal cancer.

Authors:  Mina Yu; Joo Hwan Lee; Hong Seok Jang; Dong Min Jeon; Jae Suk Cheon; Hyo Chun Lee; Jong Hoon Lee
Journal:  Radiat Oncol       Date:  2013-07-16       Impact factor: 3.481

10.  The importance of mesorectum motion in determining PTV margins in rectal cancer patients treated with neoadjuvant radiotherapy.

Authors:  Zumre Arican Alickikus; Ahmet Kuru; Barbaros Aydin; Dogukan Akcay; Ilknur Bilkay Gorken
Journal:  J Radiat Res       Date:  2020-03-23       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.